Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study-Reference-Cited by-同舟云学术

Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study

Published:2022-07-04 Issue:4 Volume:29 Page:601-609
ISSN:1898-018X
Container-title:Cardiology Journal
language:
Short-container-title:Cardiol J.

Author:

Sanmartín Fernández Marcelo,Anguita Sánchez Manuel,Arribas Fernando,Barón-Esquivias Gonzalo,Barrios Vivencio,Cosin-Sales Juan,Esteve-Pastor María Asunción,Freixa-Pamias Roman,Lekuona Iñaki,Pérez-Cabeza Alejandro I.,Ureña Isabel,Vázquez Rodríguez José Manuel,Rafols Priu Carles,Marin Francisco

Publisher

VM Media SP. zo.o VM Group SK

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study;Journal of Geriatric Cardiology;2024-07

2. Situación actual de los anticoagulantes orales de acción directa en atención primaria de España. Posicionamiento de SEMERGEN en 2023;Medicina de Familia. SEMERGEN;2024-04

3. Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approach;Expert Review of Cardiovascular Therapy;2023-11-02

4. Evolución clínica de los pacientes con FA y diabetes mellitus en la pandemia de COVID-19. Registro REFADI;REC: CardioClinics;2023-07

5. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study;Cardiology Journal;2022-12-13